3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
35
Advanced Solid Tumors
20
Carcinoma, Non-Small-Cell Lung
14
Myelodysplastic Syndromes
13
Breast Neoplasms
13
Advanced Solid Tumor
13
Recurrence
10
Ovarian Neoplasms
8
Neoplasms
8
Multiple Myeloma
8
Leukemia, Myelomonocytic, Chronic
8
Triple Negative Breast Neoplasms
7
Solid Tumor
6
Myeloproliferative Disorders
6
Small Cell Lung Carcinoma
5
Prostatic Neoplasms
5
Neoplasm Metastasis
5
Lung Neoplasms
5
Carcinoma, Hepatocellular
5
Advanced Solid Tumour
5
Sarcoma
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Melanoma
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, B-Cell
4
Fallopian Tube Neoplasms
4
Colorectal Neoplasms
4
Advanced Malignant Solid Tumor
4
Advanced Lung Cancer
4
Squamous Cell Carcinoma of Head and Neck
3
Interventions
Cisplatin
15
Pemetrexed
12
pembrolizumab
9
Carboplatin
8
Nivolumab
7
Platinum
6
Cyclophosphamide
6
Ipilimumab
5
1,2-diaminocyclohexaneplatinum II citrate
5
fludarabine
3
atezolizumab
3
Radiotherapy, Intensity-Modulated
3
Interleukin-2
3
Gemcitabine
3
tremelimumab
2
durvalumab
2
aldesleukin
2
Radiotherapy
2
Radiation
2
Photochemotherapy
2
Pharmaceutical Preparations
2
Methotrexate
2
Drug Therapy
2
Chemotherapy, Adjuvant
2
Cerebral Decortication
2
nintedanib
1
methoxyamine
1
decitabine and cedazuridine drug combination
1
cemiplimab
1
cediranib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Injections
×
1 year
×
Clear all
No trials found.